This site uses cookies to help us manage and improve the website and to analyse how visitors use our site. By continuing to use the website, you are agreeing to our use of cookies. For further information about cookies, including about how to change your browser settings to no longer accept cookies, please view our Cookie Policy. Click for more info.

M&A could be the cure for the UK's threatened pharmaceutical industry

Read Director, Karen Dawaf Harron's piece in City AM here on how M&A activity could be the key to solving the pending national drug shortage, and prevent pharmaceutical providers from stockpiling.

Karen also discusses Arrowpoint Advisory's recent part in advising Inflexion Private Equity on its investment in European LifeCare Group.

Karen Dawaf Harron

Director

Phone: +44 20 7484 4730

Mobile: +44 7901 666735